Author Interviews, Breast Cancer, Brigham & Women's - Harvard, NEJM / 22.04.2021

MedicalResearch.com Interview with: Aditya Bardia MD, MPH Director, Breast Cancer Research Program, Attending Physician, Massachusetts General Hospital Harvard Medical School [caption id="attachment_57202" align="alignleft" width="200"]Aditya Bardia MD, MPH Director, Breast Cancer Research Program, Attending Physician, Massachusetts General Hospital Harvard Medical School Dr. Bardia[/caption]  MedicalResearch.com: What is the background for this study? Response: Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer associated with guarded prognosis. For patients with pre-treated metastatic TNBC, standard chemotherapy is associated with low response rate (5-10%) and poor progression-free survival (2-3 months), highlighting need for better therapies. Sacituzumab govitecan is an antibody drug conjugate (ADC) which  combines SN-38, an active metabolite of irinotecan, with an antibody against Trop-2, an antigen overexpressed in majority of triple negative breast cancer.
Author Interviews, Psychological Science / 19.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57180" align="alignleft" width="145"]Daniel J. Kruger Ph.D. Research Investigator, Population Studies Center University of Michigan  Dr. Kruger[/caption] Daniel J. Kruger Ph.D. Research Investigator, Population Studies Center University of Michigan  MedicalResearch.com: What is the background for this study? Response: Thorstein Veblen coined the terms “conspicuous consumption” and “conspicuous leisure” to describe the wasteful habits of the upper classes in amassing and displaying expensive goods that did not have inherent practical benefits and devoting time to pursuits such as sports and fine arts. The purpose of these socially conspicuous displays and behaviors was to advertise one’s membership in the upper, leisure class, as only the very wealthy could afford them. Veblen was inspired in part by Charles Darwin’s theory of biological evolution. Darwin himself was greatly puzzled by what he considered wasteful investments of energy in elaborate physiological displays. He saw these features as the greatest threat to his theory of natural selection. Why would something like the peacock’s tail feathers evolve, as they actually threatened survival because of their impediment to foraging and avoiding predators? Darwin was so troubled by this dilemma that the sight of a peacock’s tail feather would make him feel sick. Darwin later realized that these features provided a reproductive advantage, leading to his theory of sexual selection, including the processes of inter-sexual selection and intra-sexual competition. 
Author Interviews, COVID -19 Coronavirus, Education, Pediatrics / 16.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57176" align="alignleft" width="200"]Jared Bullard MD FRCPC Associate Professor, Departments of Pediatrics & Child Health and Medical Microbiology & Infectious Diseases Max Rady College of Medicine Rady Faculty of Health Sciences Cadham Provincial Laboratory Children’s Hospital Research Institute of Manitoba Dr. Bullard[/caption] Jared Bullard MD FRCPC Associate Professor, Departments of Pediatrics & Child Health and Medical Microbiology & Infectious Diseases Max Rady College of Medicine Rady Faculty of Health Sciences Cadham Provincial Laboratory Children’s Hospital Research Institute of Manitoba MedicalResearch.com: What is the background for this study? Response: Children are well known to transmit epidemic/endemic respiratory viruses like influenza. Initial public health policy was based on that children were likely to transmit SARS-CoV-2 effectively within a community and subsequently in-person school and extracurricular activities were suspended. Initial research did not show a clear association with children driving transmission. The purpose of our study was to take respiratory samples from both children and adults with COVID-19 (all had SARS-CoV-2 detected by RT-PCR) and compare those samples by their ability to grow in cell culture and amount of virus in samples. We took 175 samples from children (97 younger than 10 years of age and 78 between 11-17 years) and compared them to 130 adult samples from the same communities in Manitoba experiencing outbreaks of COVID-19. 
Author Interviews, Psychological Science / 15.04.2021

MedicalResearch.com Interview with: Michael J. Poulin, PhD, PhD Associate Professor of Psychology College of Arts and Sciences University of Buffalo  MedicalResearch.com: What is the background for this study? Response: A great deal of research suggests that practicing mindfulness--full attention to and acceptance of one's experiences--can be good for individuals. Mindfulness seems to reduce stress and has other psychological benefits. But what about its effects on others? Does mindfulness make people more generous and helpful, or does it make them more selfish?
Author Interviews, Environmental Risks, Toxin Research / 13.04.2021

MedicalResearch.com Interview with: Elisabeth Schirmer Doctoral student University of Bayreuth, Germany plastics-bpa-bisphenols MedicalResearch.com: What is the background for this study? Response: Bisphenol A (BPA) is worldwide one of the most frequently used plasticizers. Over time it has been shown that BPA interferes with developmental processes in vertebrates, i.e. brain development. It is therefore increasingly being substituted by supposedly safe plasticizers like bisphenol S (BPS). 
Author Interviews, COVID -19 Coronavirus, Critical Care - Intensive Care - ICUs, Race/Ethnic Diversity / 13.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57126" align="alignleft" width="300"]Dr. Jennings and Dr. Lazar Dr. Jennings and Dr. Lazar[/caption] Michael H. Lazar MD Jeffrey H Jennings, MD Pulmonary and Critical Care specialists Henry Ford Hospital Detroit Michigan MedicalResearch.com: What is the background for this study? What are the main findings? Response: Persons of color who are infected with COVID-19 have a higher incidence of hospitalization and death when compared to white patients.  However, it was previously unknown if there was a difference in outcomes based upon race in patients who are sick enough to be treated in an intensive care unit (ICU). Our study found that race made no difference in ICU outcomes. MedicalResearch.com: What should readers take away from your report? Response: Lack of racial differences in survival and other meaningful outcomes in the intensive care unit may be related to the highly protocolized nature of care and experience of the critical care team.
AACR, Author Interviews, Cancer Research, MD Anderson / 12.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57124" align="alignleft" width="133"]Vivek Subbiah, MD Department of Investigational Cancer Therapeutics Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Dr. Subbiah[/caption] Vivek Subbiah, MD Department of Investigational Cancer Therapeutics Division of Cancer Medicine The University of Texas MD Anderson Cancer Center MedicalResearch.com: What is the background for this study? Response: RET fusions occur predominantly in 2% of lung cancers and 10-20% of thyroid cancers, and in low frequency in an increasing number of diverse cancers, including pancreatic cancer, salivary gland cancer, and colorectal cancer. The therapeutic relevance of RET fusions occurring outside of lung and thyroid cancers has not been well established..
Author Interviews, Exercise - Fitness, Weight Research / 10.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57111" align="alignleft" width="140"]Prof. Dr. Karsten Koehler Department of Sport and Health Sciences Technical University of Munich Prof. Koehler[/caption] Prof. Dr. Karsten Koehler Department of Sport and Health Sciences Technical University of Munich MedicalResearch.com: What is the background for this study? Response: The primary background is the phenomenon that most people fail to loose (meaningful) weight through exercise alone, which is related to what we call compensatory eating – an increase in food intake to compensate for the increased energy expenditure of exercise. This is been described in a number of studies and is considered a key weight loss barrier – yet few have come up with solutions to overcome this problem. Therefore, we wanted to see if the timing of food choices has an impact on how much and what we want to eat in the context of exercise.
Accidents & Violence, Author Interviews, Cannabis, CMAJ / 06.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57068" align="alignleft" width="200"]Sarah Windle Sarah Windle[/caption] Sarah Windle, MPH PhD Student in Epidemiology Department of Epidemiology, Biostatistics, and Occupational Health McGill University (Montréal, Québec, Canada) MedicalResearch.com: What is the background for this study? Response: Concerns have been raised about the potential for increases in impaired driving following the legalization of recreational cannabis use in Canada in October 2018. Data from Statistics Canada suggest that cannabis use in the previous three months increased among adults (15 and older) from 14% before legalization in 2018 to 17% in 2019. Among those users with a driver’s license, 13% reported driving within two hours of cannabis use. While this proportion remained the same before and after legalization, this indicates that the absolute number of individuals who reported driving within two hours of use has increased following legalization (due to an increase in the number of users).
Author Interviews, CDC, COVID -19 Coronavirus / 06.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57083" align="alignleft" width="173"]Michael S. Pollard Ph.D Senior Sociologist; Professor Pardee RAND Graduate School Dr. Pollard[/caption] Michael S. Pollard Ph.D Senior Sociologist; Professor Pardee RAND Graduate School MedicalResearch.com: What is the background for this study? Response: The Centers for Disease Control and Prevention (CDC) has traditionally been a highly trusted source of public health information, and conveying information to the public about the vaccine and broader pandemic response is critical.  This study examines changes in levels of public trust in the CDC between May and October, 2020, in light of the numerous challenges the CDC initially faced during the COVID-19 pandemic: technical problems with their COVID-19 testing kits, mixed messaging about the pandemic and mitigation strategies, and public commentary and interference by people in the Trump administration, for example.
Author Interviews, COVID -19 Coronavirus, Stroke / 06.04.2021

MedicalResearch.com Interview with: [caption id="attachment_57079" align="alignleft" width="184"]Dr. Thanh Nguyen Dr. Nguyen[/caption] Dr. Thanh Nguyen MD Director of Interventional Neurology/ Neuroradiology Boston Medical Center MedicalResearch.com: What is the background for this study? Response: During the first wave of the COVID-19 pandemic in the spring of 2020, there were many regional and sometimes national reports of declines in stroke and myocardial infarction volumes. Our goal was to understand whether these declines were also seen for other neurological emergencies such as subarachnoid hemorrhage hospitalizations and ruptured aneurysm endovascular treatments.
Author Interviews / 31.03.2021

MedicalResearch.com Interview with: [caption id="attachment_57049" align="alignleft" width="200"]Arch G. Mainous III, PhD Professor Department of Health Services Research, Management and Policy Professor and Vice Chair for Research Department of Community Health and Family Medicine University of Florida Prof. Mainous[/caption] Arch G. Mainous III, PhD Professor Department of Health Services Research, Management and Policy Professor and Vice Chair for Research Department of Community Health and Family Medicine University of Florida MedicalResearch.com: What is the background for this study? Response: We are always concerned about infections from antibiotic resistant bacteria. When the bacteria are resistant to our current treatments this lengthens the time and severity of the illness. Staphylococcus aureus is a major cause of community and healthcare associated infections. These range from skin infections to invasive infections and even death. Methicillin-resistant S. aureus (MRSA) is of particular concern and is a burden on the health care system. Importantly, patients colonized, not infected, with MRSA are more likely to develop MRSA infections and patients with MRSA infections have increased risk of hospital length of stay and even death. We are always concerned about infections from antibiotic resistant bacteria. When the bacteria are resistant to our current treatments this lengthens the time and severity of the illness. Staphylococcus aureus is a major cause of community and healthcare associated infections. These range from skin infections to invasive infections and even death. Methicillin-resistant S. aureus (MRSA) is of particular concern and is a burden on the health care system. Importantly, patients colonized, not infected, with MRSA are more likely to develop MRSA infections and patients with MRSA infections have increased risk of hospital length of stay and even death.
Author Interviews, COVID -19 Coronavirus, Education, Mental Health Research, PLoS / 23.03.2021

MedicalResearch.com Interview with: [caption id="attachment_57013" align="alignleft" width="180"]David C. Rettew, MD Child & Adolescent Psychiatrist Associate Professor of Psychiatry and Pediatrics University of Vermont Larner College of Medicine Dr. Rettew[/caption] David C. Rettew, MD Child & Adolescent Psychiatrist Associate Professor of Psychiatry and Pediatrics University of Vermont Larner College of Medicine MedicalResearch.com: What is the background for this study? Response: Our group, the Wellness Environment Scientific Team at the University of Vermont, hadn’t planned to look at COVID at the outset of this study and instead were going to look at mental health and engagement in wellness activities in college students across a semester. The pandemic disrupted that plan when students were abruptly sent home but fortunately, they continued to do their daily app-based ratings of their mood, stress levels, and engagement in healthy activities.  We then realized we had some interesting pre-COVID to COVID data that was worth exploring. 
Author Interviews, CMAJ, COVID -19 Coronavirus, OBGYNE / 19.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56997" align="alignleft" width="181"]Nathalie Auger Professeure agrégée de clinique École de santé publique - Département de médecine sociale et preventive University of Montreal Prof.Auger[/caption] Nathalie Auger Professeure agrégée de clinique École de santé publique - Département de médecine sociale et preventive University of Montreal MedicalResearch.com: What is the background for this study? Response: COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been a major public health concern. The number of infected pregnant women continues to increase. Pregnant women and infants are particularly susceptible to COVID-19 because the physiologic changes of pregnancy involve cardiovascular, respiratory, and immune changes that may alter the response to SARS-CoV-2 infection. Fetuses may be exposed to SARS-CoV-2 during critical periods of development. The nature of the association between COVID-19 and pregnancy outcomes remains unclear and meta-analyses of pregnant women with COVID-19 are lacking.
Author Interviews, Brigham & Women's - Harvard, COVID -19 Coronavirus / 17.03.2021

MedicalResearch.com Interview with: Benjamin E. Gewurz MD, PhD Broad Institute of MIT and Harvard, Cambridge, Division of Infectious Disease, Department of Medicine, Brigham and Women’s Hospital, Department of Microbiology, Harvard Medical School Boston, MABenjamin E. Gewurz MD, PhD Broad Institute of MIT and Harvard, Cambridge, Division of Infectious Disease, Department of Medicine, Brigham and Women’s Hospital, Department of Microbiology, Harvard Medical School Boston, MA  MedicalResearch.com: What is the background for this study? Response: When the Covid-19 virus infects cells, it takes over and redirects our cells resources towards the projection of virus building blocks and new viruses.  Building blocks include large amounts of RNAs that encode for the viral proteins, much as the mRNA vaccines direct our bodies to make the spike protein. We wondered how the virus changes cell metabolism in order to support the synthesis of vast amounts of viral RNAs within hours of infection.
Author Interviews, Gender Differences, Menopause, Urology / 15.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56949" align="alignleft" width="150"]Lin Yang, PhD Research Scientist/Epidemiologist Department of Cancer Epidemiology and Prevention Research  Cancer Care Alberta | Alberta Health Services | Canada Adjunct Assistant Professor Departments of Oncology and Community Health Sciences University of Calgary | Canada  Dr. Lin Yang[/caption] Lin Yang, PhD Research Scientist/Epidemiologist Department of Cancer Epidemiology and Prevention Research Cancer Care Alberta | Alberta Health Services | Canada Adjunct Assistant Professor Departments of Oncology and Community Health Sciences University of Calgary | Canada  MedicalResearch.com: What is the background for this study? Response: Urinary incontinence disproportionately affects women. Urinary incontinence results in significant physical, social, and psychological adverse consequences that impair women’s quality of life and contribute to considerable healthcare costs. At the moment, the contemporary prevalence and recent trends in urinary incontinence in US women are unknown. More importantly, there is a growing awareness that urinary incontinence is not part of normal aging, but very little information is available to inform prevention strategies. Therefore, we were also interested in exploring correlates of urinary incontinence in a population-based sample of US women.
Author Interviews, COVID -19 Coronavirus, Infections, UCSD / 13.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56929" align="alignleft" width="200"]Abhishek Saha, PhD Assistant Professor Department of Mechanical and Aerospace Engineering University of California San Diego Dr. Saha[/caption] Abhishek Saha, PhD Assistant Professor Department of Mechanical and Aerospace Engineering University of California San Diego MedicalResearch.com: What is the background for this study? Response: At a very early stage of COVID 19 pandemic, the scientific community identified that respiratory droplet is the primary mode of transmission of the SARS-CoV2 virus. Naturally, the health agencies have encouraged facemasks to restrict these droplets from spreading during respiratory events, like coughing, sneezing, talking, etc. While WHO recommended using either N95 masks or other types of three-layer masks, due to a sharp increase in demand and scarcity in supplies, a variety of either home-made or locally purchased masks became popular. Naturally, one wonders if these single- and double-layer masks provide enough protection. To provide some insight into this critical question, our team, which also includes Professor Swetaprovo Chaudhuri from the University of Toronto, and Professor Saptarshi Basu of the Indian Institute of Science, experimentally analyzed what happens to the respiratory droplets when they impact single- and multi-layer masks. 
Author Interviews, Blood Pressure - Hypertension, Pediatrics / 12.03.2021

MedicalResearch.com Interview with: Melanie Clark PhD candidate Murdoch Children's Research Institute The Royal Children's Hospital  blood-pressure-children-hypertensionMedicalResearch.com: What is the background for this study? What are the main findings? Response: Hypertension in children is a growing problem around the world, but when diagnosing hypertension, most of the time blood pressure is only measured in one arm. Our study showed that children can have a blood pressure difference between arms that may be considered significant in a clinical setting. One in four children had a difference between left and right arms that could mean that blood pressure appears normal in one arm, but in the other arm it would be classified as a high blood pressure. This means that if a doctor measures blood pressure in one arm only, a diagnosis of high blood pressure could be missed.
Author Interviews, CDC, COVID -19 Coronavirus, Emory, JAMA, Occupational Health / 12.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56923" align="alignleft" width="107"]Jesse T. Jacob, MD School of Medicine Director, Antibiotic Stewardship Program Emory University, Atlanta, Georgia Dr. Jacob[/caption] Jesse T. Jacob, MD School of Medicine Director, Antibiotic Stewardship Program Emory University, Atlanta, Georgia MedicalResearch.com: What is the background for this study? Response: Since coronavirus disease 2019 (COVID-19) was recognized in the United States in January 2020, the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attributed to exposures in the health care workplace has been studied with conflicting results, and the role of job functions (such as nurse) or specific workplace activities, including care for individuals with known and unknown SARS-CoV-2 positivity, increase the risk of SARS-CoV-2 infection. We assessed more than 24,000 healthcare providers between April and August 2020 across four large academic medical systems (Emory, Johns Hopkins, Rush University Medical Center, and University of Maryland) which collaborate in the CDC’s Prevention Epicenter Program and conduct innovative infection prevention research. Each site conducted voluntary COVID-19 antibody testing on its health care workers, as well as offered a questionnaire/survey on the employees’ occupational activities and possible exposures to individuals with COVID-19 infection both inside and outside the workplace. We also looked at three-digit residential zip-code prefixes to determine COVID-19 prevalence in communities.  
Author Interviews, Chocolate, Heart Disease / 09.03.2021

MedicalResearch.com Interview with: Anne Yuk-Lam Ho, MPH Million Veteran Program (MVP) Data Core MVP Coordinating Center VA Boston Healthcare SystemAnne Yuk-Lam Ho, MPH Million Veteran Program (MVP) Data Core MVP Coordinating Center VA Boston Healthcare System MedicalResearch.com: What is the background for this study? Response: Cardiovascular disease (CVD) has been the leading cause of morbidity and mortality globally. Prevalence of CVD among US population is approximately 7% which places huge burden on our healthcare systems. And prevalence of CVD is as high as 28% among veterans at the VA healthcare system as veteran users are primarily older male with more histories of comorbidities.  Most CVD risk factors including lipids and blood pressure can be controlled by lifestyle modifications, such as diet. Chocolate is among dietary factors that play a role in modulating CVD risk factors is widely consumed in the US (~2.8 billion pounds annually. Although previous studies have reported beneficial effects of chocolate and/or cacao products (rich in flavonoids) on lipids, glucose metabolism and risk of diabetes, and lipids, little is known about the association of chocolate intake with coronary artery disease (CAD) among US veterans. Thus, sought to test the hypothesis that chocolate consumption is associated with a lower risk of CAD among xxx US veterans enrolled in the Million Veteran Program. 
Annals Internal Medicine, Author Interviews, COVID -19 Coronavirus, Tobacco, Tobacco Research, UCLA / 09.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56890" align="alignleft" width="125"]Brian P. Lee, MD, MAS Assistant Professor Clinical Medicine University of Southern Californi Keck School of Medicine Los Angeles, California Dr. Lee[/caption] Brian P. Lee, MD, MAS Assistant Professor Clinical Medicine University of Southern Californi Keck School of Medicine Los Angeles, California MedicalResearch.com: What is the background for this study? Response: The COVID-19 pandemic has been associated with mental health stressors, including anxiety, loneliness, and social instability. We hypothesized the pandemic may have led to increased alcohol and tobacco use as a coping mechanism for these stressors. National retrospective questionnaires had suggested higher reports of substance use, but these are limited by selection and recall biases, in addition to subjective report – we sought to address this knowledge gap by using a nationally-representative longitudinal cohort (Nielsen National Consumer Panel) tracking real-time purchases of households across the US. 
Author Interviews, Environmental Risks, Pediatrics, Toxin Research, Weight Research / 08.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56864" align="alignleft" width="130"]Alison P. Sanders, PhD Pronouns:  She/Her Assistant Professor Icahn School of Medicine at Mount Sinai Department of Environmental Medicine and Public Health Department of Pediatrics Director, Interdisciplinary Environmental Health Postdoctoral Fellowship Dr. Sanders[/caption] Alison P. Sanders, PhD Pronouns:  She/Her Assistant Professor Icahn School of Medicine at Mount Sinai Department of Environmental Medicine and Public Health Department of Pediatrics Director, Interdisciplinary Environmental Health Postdoctoral Fellowship MedicalResearch.com: What is the background for this study? Response: My research group is dedicated to understanding environmental and early life risk factors that contribute to kidney function declineWhile some of the pathobiology leading to chronic kidney disease remains unclear, we understand that the process is complex and, like many chronic diseases, begins long before clinical diagnosis. My research investigates how the environment and mixtures of environmental chemicals/toxicants interact with traditional risk factors such as obesity, preterm birth, and nutritional status to hasten or prevent chronic kidney disease.
Author Interviews, Diabetes, FDA, JAMA / 07.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56860" align="alignleft" width="200"]Marie C. Bradley, PhD, MPharm, MScPH Office of Surveillance and Epidemiology Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring, Maryland Dr. Bradley[/caption] Marie C. Bradley, PhD, MPharm, MScPH Office of Surveillance and Epidemiology Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring, Maryland MedicalResearch.com: What is the background for this study? Response: Long-acting insulin analogs, insulin glargine (glargine) and insulin detemir (detemir) are increasingly used in the management of type 2 diabetes mellitus (T2DM).  In recent years the price of long-acting insulin analogs has increased substantially2 Higher costs for these insulin analogs may limit patient access.1 Clinical trials showed the risk of severe hypoglycemia did not differ between long-acting insulin analogs and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes mellitus (T2DM). An observational study examining severe hypoglycemia in T2DM patients found similar results. However, these previous studies did not focus on patients aged ≥65 years, who are at an increased risk for hypoglycemia, or did not include patients with concomitant prandial insulin use. Therefore, to investigate this further we used Medicare data to assess the risk of severe hypoglycemia among older T2DM patients who initiated a long acting analog ( glargine or detemir) compared to NPH in real-world settings.
Author Interviews, Cost of Health Care, COVID -19 Coronavirus, Critical Care - Intensive Care - ICUs, JAMA / 05.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56832" align="alignleft" width="160"]Ninh T. Nguyen, MD Chief of Gastrointestinal Division, Surgery UCI Dr. Nguyen[/caption] Ninh T. Nguyen, MD Chief of Gastrointestinal Division, Surgery UCI  MedicalResearch.com: What is the background for this study? What are the main findings  Response: There are limited national data on hospitalized patients in the US. To our knowledge, the current publication provides data on the largest cohort of COVID-19 patients hospitalized at US academic centers.
AHA Journals, Author Interviews, Heart Disease, Race/Ethnic Diversity, Stroke / 05.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56856" align="alignleft" width="149"]Fernando D Testai, MD, PhD, FAHA Associate Professor of Neurology and Rehabilitation Stroke Medical Director University of Illinois Health Dr. Testai[/caption] Fernando D Testai, MD, PhD, FAHA Associate Professor of Neurology and Rehabilitation Stroke Medical Director University of Illinois Health MedicalResearch.com: What is the background for this study? Response: Stroke constitutes a leading cause of disability and mortality in the United States. Large observational studies have shown that up to 90% of the strokes are caused by modifiable vascular risk factors, including hypertension, diabetes mellitus, and several others. In addition, previous history of stroke is one of the most powerful predictors of recurrent stroke. Thus, controlling vascular risk factors in patients with stroke is of paramount importance. To this end, the American Heart Association and the American Stroke Association have developed specific targets for blood pressure, glycemic, and cholesterol levels.
Author Interviews, Columbia, COVID -19 Coronavirus, Exercise - Fitness, Heart Disease, JAMA / 05.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56853" align="alignleft" width="133"]David J. Engel, MD, FACC Division of Cardiology Columbia University Irving Medical Center New York, New York Dr. Engel[/caption] David J. Engel, MD, FACC Division of Cardiology Columbia University Irving Medical Center New York, New York MedicalResearch.com: What is the background for this study? Response: Early reports and observations in the COVID-19 pandemic found that patients recovering from mild to severe forms of COVID-19 illness had a higher prevalence of cardiac injury in comparison with what historically has been seen and reported with other viruses. This cardiac injury, categorized as inflammatory heart disease, could have serious implications, including a risk for exercise-triggered sudden cardiac death, for athletes and highly active people who have had prior COVID-19 illness and who return to intensive exercise activity with unknowing subclinical cardiac injury. To address these concerns in COVID positive athletes, the ACC generated return to play cardiac screening recommendations (troponin blood test, ECG, resting echocardiogram) for all competitive athletes after COVID-19 infection prior to resumption of competitive and intensive sport activity. The professional leagues were among the first organizations to return to full-scale sport activity in the setting of the pandemic, and they uniformly adopted and implemented the ACC return to play screening recommendations for all athletes that tested positive for COVID-19. The leagues recognized that there was value in collaborating and formally analyzing their pooled cardiac data, not only for league athlete health and safety purposes, but also to share broadly this information to add to the growing body of knowledge about the virus.
Author Interviews, Breast Cancer, Brigham & Women's - Harvard, Stem Cells / 05.03.2021

MedicalResearch.com Interview with: [caption id="attachment_56841" align="alignleft" width="163"]Khalid Shah, MS, PhD Vice Chair of Research, Department of Neurosurgery Director, Center for Stem Cell Therapeutics and Imaging Director, Center for Excellence in Biomedicine Brigham and Women's Hospital Associate Professor, Harvard Medical School Principal Faculty, Harvard Stem Cell Institute Dr. Shah[/caption] Khalid Shah, MS, PhD Vice Chair of Research, Department of Neurosurgery Director, Center for Stem Cell Therapeutics and Imaging Director, Center for Excellence in Biomedicine Brigham and Women's Hospital Associate Professor, Harvard Medical School Principal Faculty, Harvard Stem Cell Institute  MedicalResearch.com: What is the background for this study? Response: Approximately 15-to-30 percent of patients with metastatic breast cancer have brain metastasis (BM), with basal-like breast cancer (BLBC) metastasizing to the brain most frequently. The prognosis for BLBC-BM patients is poor, as the blood-brain barrier prevents most therapeutics from reaching the brain. Testing candidate therapies in clinical trials is also challenging because animal models that mimic BM are limited. In this study we engineered a bimodal tumor-suppressing and killing molecule that can be delivered to the brain by stem cells and tested them in mouse models of brain metastases that mimic clinical setting.
Thank you for visiting MedicalResearch.com Senior Editor, Marie Benz MD. For more information please email: info@MedicalResearch.com

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.